Skip to main content

. 1990 Jun 2;300(6737):1466. doi: 10.1136/bmj.300.6737.1466-a

Enalapril and metoprolol in diabetic nephropathy.

P Sawicki, L Heinemann, I Mühlhauser

PMCID: PMC1663162 PMID: 2379011

1466

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Björck S., Mulec H., Johnsen S. A., Nyberg G., Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. BMJ. 1990 Apr 7;300(6729):904–907. doi: 10.1136/bmj.300.6729.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
Björck S., Nyberg G., Mulec H., Granerus G., Herlitz H., Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):471–474. doi: 10.1136/bmj.293.6545.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
Puska P., Iacono J. M., Nissinen A., Korhonen H. J., Vartianinen E., Pietinen P., Dougherty R., Leino U., Mutanen M., Moisio S. Controlled, randomised trial of the effect of dietary fat on blood pressure. Lancet. 1983 Jan 1;1(8314-5):1–5. doi: 10.1016/s0140-6736(83)91556-8. [DOI] [PubMed] [Google Scholar]
Sawicki P. T., Mühlhauser I., Baba T., Berger M. Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia. 1990 Feb;33(2):121–124. doi: 10.1007/BF00401052. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES